Work

Therapeutic Potential of a Combined Cannabidiol (cbd) - Delta-9-tetrahydrocannabinol (thc) Treatment Strategy for Appswe/ps1δe9 Transgenic Mice

Year: 2023
Type: article
Abstract: Limited pharmacological options are available for the treatment and management of Alzheimer’s disease (AD). Cannabinoid therapy is a novel treatment strategy for AD, with preclinical evidence suggesting that cannabidiol (CBD) can ameliorate AD-related pathologies, including amyloid-β aggregation and tau hyperphosphorylation, and reverse and prevent cognitive decline in AD rodent models. Interestingly, low-dose delta-9-tetrahydrocannabinol (THC) can improve the cognition of aged mice. Importantly, when combining both cannabinoids at a ratio of 1:1, CBD+THC exhibits a greater therapeutic profile in AD mouse models than either phytocannabinoid alone.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W4388364126
FWCI:
Cites:
Cited by:
Related to: 10